- Braxia Scientific (OTCPK:BRAXF): FQ2 Net loss for the quarter decreased 16% Y/Y to $1.71M.
- Revenue of C$0.39M (+56.0% Y/Y)
- Press Release
- The Company's cash and cash equivalents as of September 30, 2021, was C$9.61M compared with C$10.26M at June 30, 2021.
Braxia Scientific reports FQ2 results
Recommended For You
More Trending News
About BRAXF Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BRAXF | - | - |
Braxia Scientific Corp. |